{"id":"placebo-for-dronedarone","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo serves as a comparator arm in randomized controlled trials to establish the efficacy of the active drug (dronedarone) by isolating its true therapeutic effect from placebo response. Any observed benefits in the placebo group reflect natural disease progression, regression to the mean, and psychological/expectation effects rather than pharmacological action.","oneSentence":"Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:36:08.672Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in clinical trials for dronedarone (atrial fibrillation management)"}]},"trialDetails":[{"nctId":"NCT04704050","phase":"PHASE4","title":"Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence","status":"TERMINATED","sponsor":"Tulane University School of Medicine","startDate":"2021-05-15","conditions":"Atrial Fibrillation, Atrial Fibrillation Recurrent","enrollment":22},{"nctId":"NCT02618577","phase":"PHASE3","title":"Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes","status":"TERMINATED","sponsor":"Atrial Fibrillation Network","startDate":"2016-02","conditions":"Atrial High Rate Episodes","enrollment":2608},{"nctId":"NCT05655468","phase":"PHASE4","title":"Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2023-03-29","conditions":"Atrial Fibrillation","enrollment":268},{"nctId":"NCT01522651","phase":"PHASE2","title":"Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2012-01-24","conditions":"Atrial Fibrillation","enrollment":134},{"nctId":"NCT01026090","phase":"PHASE4","title":"Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)","status":"TERMINATED","sponsor":"Sanofi","startDate":"2009-11","conditions":"Atrial Fibrillation","enrollment":292},{"nctId":"NCT01213368","phase":"PHASE2","title":"Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-09","conditions":"Atrial Fibrillation","enrollment":181},{"nctId":"NCT01135017","phase":"PHASE4","title":"Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers","status":"TERMINATED","sponsor":"Sanofi","startDate":"2010-07","conditions":"Atrial Fibrillation","enrollment":112},{"nctId":"NCT01198873","phase":"PHASE4","title":"Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement","status":"TERMINATED","sponsor":"Sanofi","startDate":"2010-09","conditions":"Atrial Fibrillation","enrollment":76},{"nctId":"NCT01151137","phase":"PHASE3","title":"Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy","status":"TERMINATED","sponsor":"Sanofi","startDate":"2010-07","conditions":"Atrial Fibrillation","enrollment":3236},{"nctId":"NCT01070667","phase":"PHASE4","title":"Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation","status":"UNKNOWN","sponsor":"Eastbourne General Hospital","startDate":"2010-03","conditions":"Paroxysmal Atrial Fibrillation","enrollment":50},{"nctId":"NCT00489736","phase":"PHASE3","title":"Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-06","conditions":"Atrial Fibrillation","enrollment":504},{"nctId":"NCT00259376","phase":"PHASE3","title":"American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus Rhythm","status":"COMPLETED","sponsor":"Sanofi","startDate":"2001-11","conditions":"Atrial Fibrillation, Atrial Flutter","enrollment":629},{"nctId":"NCT00259428","phase":"PHASE3","title":"EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2001-11","conditions":"Atrial Fibrillation, Atrial Flutter","enrollment":615},{"nctId":"NCT00174785","phase":"PHASE3","title":"A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation","status":"COMPLETED","sponsor":"Sanofi","startDate":"2005-06","conditions":"Atrial Fibrillation, Atrial Flutter","enrollment":4628},{"nctId":"NCT00697086","phase":"PHASE3","title":"European Study of Dronedarone in Atrial Fibrillation","status":"COMPLETED","sponsor":"Sanofi","startDate":"2002-08","conditions":"Atrial Fibrillation","enrollment":174}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":103,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo (for dronedarone)","genericName":"Placebo (for dronedarone)","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dronedarone is a small molecule that blocks the voltage-gated L-type calcium channel, classified as a blocker. It is used to treat conditions such as atrial fibrillation, paroxysmal atrial fibrillation, and atrial flutter, and is compared to a placebo in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}